Impact of early abciximab administration on myocardial reperfusion in patients with ST-segment elevation myocardial infarction pretreated with 600 mg of clopidogrel before percutaneous coronary intervention.
about
Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectivesAntithrombotic therapy before, during and after emergency angioplasty for ST elevation myocardial infarction.Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled tria
P2860
Impact of early abciximab administration on myocardial reperfusion in patients with ST-segment elevation myocardial infarction pretreated with 600 mg of clopidogrel before percutaneous coronary intervention.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Impact of early abciximab admi ...... taneous coronary intervention.
@en
Impact of early abciximab admi ...... taneous coronary intervention.
@nl
type
label
Impact of early abciximab admi ...... taneous coronary intervention.
@en
Impact of early abciximab admi ...... taneous coronary intervention.
@nl
prefLabel
Impact of early abciximab admi ...... taneous coronary intervention.
@en
Impact of early abciximab admi ...... taneous coronary intervention.
@nl
P2093
P50
P1476
Impact of early abciximab admi ...... utaneous coronary intervention
@en
P2093
Andrzej Ochala
Bogdan Janus
Dawid Giszterowicz
Jacek Legutko
Jacek S Dubiel
Jaroslaw Zalewski
Leszek Bryniarski
Pawel Wieja
Tomasz Rakowski
Wojciech Dobrowolski
P2860
P2888
P304
P356
10.1007/S11239-010-0461-9
P577
2010-10-01T00:00:00Z